About

Sayan Bhattacharya is an Assistant Professor in the Harriet Tubman Department of Women, Gender, and Sexuality Studies at the University of Maryland. They earned their doctorate in Feminist Studies from the University of Minnesota. Their research focuses on ethnographic and archival explorations of Indian trans communities, examining strategies they deploy to navigate environments saturated by violence. Their work explores gestures of pleasure, negotiations with the state, care labor, and dark humor as means for trans communities to endure and refuse violence. Bhattacharya's scholarship stages conversations between anthropologies of everyday life, trans, queer, and critical disability studies, as well as anti-caste literatures, to study efforts to reproduce inhabitable everyday spaces. Their research has been published in various academic journals including Radical History Review, Global Public Health, Transgender Studies Quarterly, and others. They received the 2023 Sylvia Rivera Award in Transgender Studies for their essay on transgender life-making during the pandemic. Additionally, Bhattacharya volunteers with community-led trans and disability rights organizations in West Bengal, India.

Research topics

• Internal medicine
• Cancer research
• Oncology
• Immunology
• Cell biology
• Biochemistry
• Medicine
• Biology

Selected publications

• Advances in Glioblastoma Therapy: An Update on Current Approaches

  Brain Sciences · 2023 · 193 citations

  Senior authorCorresponding
  • Medicine
  • Oncology
  • Immunology

  Glioblastoma multiforme (GBM) is a primary malignant brain tumor characterized by a high grade of malignancy and an extremely unfavorable prognosis. The current efficacy of established treatments for GBM is insufficient, necessitating the prompt development of novel therapeutic approaches. The progress made in the fundamental scientific understanding of GBM is swiftly translated into more advanced stages of therapeutic studies. Despite extensive efforts to identify new therapeutic approaches, GBM exhibits a high mortality rate. The current efficacy of treatments for GBM patients is insufficient due to factors such as tumor heterogeneity, the blood-brain barrier, glioma stem cells, drug efflux pumps, and DNA damage repair mechanisms. Considering this, pharmacological cocktail therapy has demonstrated a growing efficacy in addressing these challenges. Towards this, various forms of immunotherapy, including the immune checkpoint blockade, chimeric antigen receptor T (CAR T) cell therapy, oncolytic virotherapy, and vaccine therapy have emerged as potential strategies for enhancing the prognosis of GBM. Current investigations are focused on exploring combination therapies to mitigate undesirable side effects and enhance immune responses against tumors. Furthermore, clinical trials are underway to evaluate the efficacy of several strategies to circumvent the blood-brain barrier (BBB) to achieve targeted delivery in patients suffering from recurrent GBM. In this review, we have described the biological and molecular targets for GBM therapy, pharmacologic therapy status, prominent resistance mechanisms, and new treatment approaches. We also discuss these promising therapeutic approaches to assess prospective innovative therapeutic agents and evaluated the present state of preclinical and clinical studies in GBM treatment. Overall, this review attempts to provide comprehensive information on the current status of GBM therapy.

  DOI

• Biophysical, Molecular and Proteomic Profiling of Human Retinal Organoid-Derived Exosomes

  Pharmaceutical Research · 2022 · 41 citations

  • Cell biology
  • Biology
  • Biochemistry
  DOI

Frequent coauthors

• Debabrata Mukhopadhyay

  Nemours Children's Clinic

  64 shared

• Enfeng Wang

  Nemours Children's Clinic

  42 shared

• Tanmay Kulkarni

  Mayo Clinic in Florida

  41 shared

• Ramcharan Singh Angom

  Jacksonville College

  31 shared

• Shamit K. Dutta

  Jacksonville College

  31 shared

• Krishnendu Pal

  Mayo Clinic in Florida

  24 shared

• T. Venkatesan

  University of Oklahoma

  21 shared

• X. X. Xi

  Lanzhou University

  15 shared

Education

• Ph.D., Feminist Studies

  University of Minnesota

Awards & honors

• 2023 Sylvia Rivera Award in Transgender Studies

Similar researchers at University of Maryland, College Park

• Sankar Das Sarmah-141
• Arie Kruglanskih-106
• John C. Haltiwangerh-99
• Matthew C. Hansenh-97
• Michel Wedelh-85